FLQ-101
Retinopathy of Prematurity (ROP)
Phase 1bActive
Key Facts
About Feliqs
Clinical-stage ophthalmology company developing innovative therapies for retinopathy of prematurity and age-related macular degeneration.
View full company profileTherapeutic Areas
Other Retinopathy of Prematurity (ROP) Drugs
| Drug | Company | Phase |
|---|---|---|
| Vitamin A Palmitate Platform | Advent Therapeutics | Unknown |